These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 8566040)

  • 1. Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies.
    Wijdenes J; Heinrich PC; Müller-Newen G; Roche C; Gu ZJ; Clément C; Klein B
    Eur J Immunol; 1995 Dec; 25(12):3474-81. PubMed ID: 8566040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor.
    Liautard J; Sun RX; Cotte N; Gaillard JP; Mani JC; Klein B; Brochier J
    Cytokine; 1997 Apr; 9(4):233-41. PubMed ID: 9112331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
    Westendorf JJ; Jelinek DF
    J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-specific utilization of the extracellular membrane-proximal region of the gp130-related signalling receptors.
    Hammacher A; Wijdenes J; Hilton DJ; Nicola NA; Simpson RJ; Layton JE
    Biochem J; 2000 Jan; 345 Pt 1(Pt 1):25-32. PubMed ID: 10600635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the gp130 signaling pathway by monoclonal antibodies directed against the gp130 molecule.
    Autissier P; Liautard J; Brochier J; Gaillard JP
    Eur J Immunol; 1997 Mar; 27(3):794-7. PubMed ID: 9079824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein.
    Chevalier S; Fourcin M; Robledo O; Wijdenes J; Pouplard-Barthelaix A; Gascan H
    J Biol Chem; 1996 Jun; 271(25):14764-72. PubMed ID: 8662918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of gp130/interleukin-6 receptor transducing component in interleukin-11 receptor.
    Fourcin M; Chevalier S; Lebrun JJ; Kelly P; Pouplard A; Wijdenes J; Gascan H
    Eur J Immunol; 1994 Jan; 24(1):277-80. PubMed ID: 8020567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
    Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
    J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 receptor antagonists inhibit interleukin-11 biological activity.
    Sun RX; Gennaro C; Rocco S; Gu ZJ; Klein B
    Eur Cytokine Netw; 1997 Mar; 8(1):51-6. PubMed ID: 9110148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines involving gp130 in signal transduction suppressed growth of a mouse hybridoma cell line and enhanced its antibody production.
    Terada S; Suzuki E; Ueda H; Makishima F
    Cytokine; 1996 Dec; 8(12):889-94. PubMed ID: 9050746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
    Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
    Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. gp130 and the IL-6 family of cytokines: signaling mechanisms and thrombopoietic activities.
    Nakashima K; Taga T
    Semin Hematol; 1998 Jul; 35(3):210-21. PubMed ID: 9685167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cytokine receptor gp130: faithfully promiscuous.
    Müller-Newen G
    Sci STKE; 2003 Sep; 2003(201):PE40. PubMed ID: 14506288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction.
    Yin T; Taga T; Tsang ML; Yasukawa K; Kishimoto T; Yang YC
    J Immunol; 1993 Sep; 151(5):2555-61. PubMed ID: 8360477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble glycoprotein 130 (gp130) attenuates OSM- and LIF-induced cartilage proteoglycan catabolism.
    Hui W; Bell M; Carroll G
    Cytokine; 2000 Feb; 12(2):151-5. PubMed ID: 10671300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
    Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
    Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily.
    Hirano T; Matsuda T; Nakajima K
    Stem Cells; 1994 May; 12(3):262-77. PubMed ID: 8075593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
    Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
    Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.